29418-67-5,MFCD00051577
Catalog No.:AA00BCDC

29418-67-5 | 2-Bromobenzhydrazide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$35.00   $25.00
- +
5g
>98.0%(GC)(T)
in stock  
$78.00   $55.00
- +
10g
97%
in stock  
$154.00   $108.00
- +
25g
97%
in stock  
$202.00   $142.00
- +
100g
97%
in stock  
$583.00 $408.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00BCDC
Chemical Name:
2-Bromobenzhydrazide
CAS Number:
29418-67-5
Molecular Formula:
C7H7BrN2O
Molecular Weight:
215.0473
MDL Number:
MFCD00051577
SMILES:
C1=CC=C(C(=C1)C(=O)NN)Br
NSC Number:
522536
Properties
Properties
 
Form:
Solid  
MP:
152-154°C  
Storage:
Room Temperature;  

Computed Properties
 
Complexity:
151  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.3  

Downstream Synthesis Route

[1]Patent:CN105481765,2016,A.Locationinpatent:Paragraph0084;0085;0086

[2]BioorganicandMedicinalChemistry,2015,vol.23,p.6014-6024

[3]ScienceReportsofNationalTsingHuaUniversity,SeriesA:Mathematical,Physical,andEngineeringSciences,1936,vol.<A>3,p.555,558    JournaloftheChineseChemicalSociety(Peking),1936,vol.4,p.69,72

[4]EuropeanJournalofMedicinalChemistry,2010,vol.45,p.6085-6089

[5]Lettersindrugdesignanddiscovery,2012,vol.9,p.135-139

[6]JournalofHeterocyclicChemistry,2013,vol.50,p.945-948

[7]MedicinalChemistryResearch,2014,vol.23,p.2080-2092

[8]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.5154-5156

[9]RSCAdvances,2015,vol.5,p.12807-12820

[10]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.3052-3056

[11]AsianJournalofChemistry,2015,vol.27,p.3605-3608

[12]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2016,vol.55B,p.207-212

[13]ChemMedChem,2017,vol.12,p.972-985

[14]ChemicalBiologyandDrugDesign,2017,vol.90,p.236-243

[15]BioorganicandMedicinalChemistry,2017,vol.25,p.5652-5661

[16]ArchivderPharmazie,2017,vol.350

[17]RSCAdvances,2018,vol.8,p.6306-6314

[18]EuropeanJournalofPharmaceuticalSciences,2019,vol.136

[19]ArchivderPharmazie,2019,vol.352

[20]BioorganicChemistry,2020,vol.94

[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1987,vol.26,p.526-531

[2]JournaloftheKoreanChemicalSociety,2010,vol.54,p.731-736

[3]ChemicalBiologyandDrugDesign,2017,vol.89,p.47-60

75-15-0    29418-67-5   
5-(2-bromophenyl)-1,3,4-oxadiazole-2-thione 

[1]JournaloftheChemicalSocietyofPakistan,2014,vol.36,p.852-857

[2]JournalofHeterocyclicChemistry,1994,vol.31,p.1593-1598

[3]BioorganicandMedicinalChemistry,2014,vol.22,p.1008-1015

[4]ChemMedChem,2017,vol.12,p.972-985

[5]BiomedicineandPharmacotherapy,2022,vol.146

[1]BioorganicandMedicinalChemistry,2005,vol.13,p.4842-4850

[2]JournaloftheChileanChemicalSociety,2012,vol.57,p.1492-1496

[3]ChemicalCommunications,2014,vol.50,p.9914-9916

[4]Patent:US2005/250753,2005,A1.Locationinpatent:Page/Pagecolumn71

[5]Chemistry-AnAsianJournal,2010,vol.5,p.543-549

[6]ZeitschriftfurNaturforschung,B:ChemicalSciences,2010,vol.65,p.178-184

[7]MonatsheftefurChemie,2010,vol.141,p.479-484

[8]JournalofAgriculturalandFoodChemistry,2012,vol.60,p.1036-1041

[9]MedicinalChemistry,2012,vol.8,p.1190-1197,8

[10]ChemicalBiologyandDrugDesign,2013,vol.82,p.546-556

[11]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.192-194

[12]JournalofMolecularStructure,2016,vol.1117,p.8-16

[13]ChemicalBiologyandDrugDesign,2017,vol.89,p.47-60

[14]BioorganicandMedicinalChemistryLetters,2019,vol.29,p.449-453

[15]Molecules,2020,vol.25

[16]Bioorganicandmedicinalchemistryletters,2020

[17]MonatsheftefurChemie,2021,vol.152,p.121-135

[18]BioorganicandMedicinalChemistryLetters,2021,vol.34

[19]EuropeanJournalofMedicinalChemistry,2021,vol.217

[20]BioorganicChemistry,2021,vol.110

[21]BiomedicineandPharmacotherapy,2022,vol.146

[22]JournalofMaterialsChemistryC,2022,vol.10,p.1371-1380

[1]JournaloftheChineseChemicalSociety,2005,vol.52,p.539-544

[2]JournalofAgriculturalandFoodChemistry,2012,vol.60,p.1036-1041

[3]ChemicalBiologyandDrugDesign,2013,vol.82,p.546-556

[4]JournalofChemicalSciences,2014,vol.126,p.827-835

[5]ChemicalBiologyandDrugDesign,2017,vol.90,p.236-243

[6]JournalofAgriculturalandFoodChemistry,2021,vol.69,p.11085-11094

[7]JournalofAgriculturalandFoodChemistry,2021,vol.69,p.15544-15553

[8]MolecularDiversity,2022

Literature

Title: Evaluation of small molecule tuberculostats for targeting tuberculosis infections of the central nervous system.

Journal: Central nervous system agents in medicinal chemistry 20120301

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:29418-67-5 Molecular Formula|29418-67-5 MDL|29418-67-5 SMILES|29418-67-5 2-Bromobenzhydrazide
Catalog No.: AA00BCDC
29418-67-5,MFCD00051577
29418-67-5 | 2-Bromobenzhydrazide
Pack Size: 1g
Purity: 97%
in stock
$35.00 $25.00
Pack Size: 5g
Purity: >98.0%(GC)(T)
in stock
$78.00 $55.00
Pack Size: 10g
Purity: 97%
in stock
$154.00 $108.00
Pack Size: 25g
Purity: 97%
in stock
$202.00 $142.00
Pack Size: 100g
Purity: 97%
in stock
$583.00 $408.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00BCDC
Chemical Name: 2-Bromobenzhydrazide
CAS Number: 29418-67-5
Molecular Formula: C7H7BrN2O
Molecular Weight: 215.0473
MDL Number: MFCD00051577
SMILES: C1=CC=C(C(=C1)C(=O)NN)Br
NSC Number: 522536
Properties
Form: Solid  
MP: 152-154°C  
Storage: Room Temperature;  
Complexity: 151  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 11  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.3  
Downstream Synthesis Route
6091-64-1    29418-67-5 

[1]Patent:CN105481765,2016,A.Locationinpatent:Paragraph0084;0085;0086

[2]BioorganicandMedicinalChemistry,2015,vol.23,p.6014-6024

[3]ScienceReportsofNationalTsingHuaUniversity,SeriesA:Mathematical,Physical,andEngineeringSciences,1936,vol.<A>3,p.555,558    JournaloftheChineseChemicalSociety(Peking),1936,vol.4,p.69,72

[4]EuropeanJournalofMedicinalChemistry,2010,vol.45,p.6085-6089

[5]Lettersindrugdesignanddiscovery,2012,vol.9,p.135-139

[6]JournalofHeterocyclicChemistry,2013,vol.50,p.945-948

[7]MedicinalChemistryResearch,2014,vol.23,p.2080-2092

[8]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.5154-5156

[9]RSCAdvances,2015,vol.5,p.12807-12820

[10]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.3052-3056

[11]AsianJournalofChemistry,2015,vol.27,p.3605-3608

[12]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2016,vol.55B,p.207-212

[13]ChemMedChem,2017,vol.12,p.972-985

[14]ChemicalBiologyandDrugDesign,2017,vol.90,p.236-243

[15]BioorganicandMedicinalChemistry,2017,vol.25,p.5652-5661

[16]ArchivderPharmazie,2017,vol.350

[17]RSCAdvances,2018,vol.8,p.6306-6314

[18]EuropeanJournalofPharmaceuticalSciences,2019,vol.136

[19]ArchivderPharmazie,2019,vol.352

[20]BioorganicChemistry,2020,vol.94

29418-67-5    333-20-0    39631-31-7 

[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1987,vol.26,p.526-531

[2]JournaloftheKoreanChemicalSociety,2010,vol.54,p.731-736

[3]ChemicalBiologyandDrugDesign,2017,vol.89,p.47-60

75-15-0    29418-67-5   
5-(2-bromophenyl)-1,3,4-oxadiazole-2-thione 

[1]JournaloftheChemicalSocietyofPakistan,2014,vol.36,p.852-857

[2]JournalofHeterocyclicChemistry,1994,vol.31,p.1593-1598

[3]BioorganicandMedicinalChemistry,2014,vol.22,p.1008-1015

[4]ChemMedChem,2017,vol.12,p.972-985

[5]BiomedicineandPharmacotherapy,2022,vol.146

610-94-6    29418-67-5 

[1]BioorganicandMedicinalChemistry,2005,vol.13,p.4842-4850

[2]JournaloftheChileanChemicalSociety,2012,vol.57,p.1492-1496

[3]ChemicalCommunications,2014,vol.50,p.9914-9916

[4]Patent:US2005/250753,2005,A1.Locationinpatent:Page/Pagecolumn71

[5]Chemistry-AnAsianJournal,2010,vol.5,p.543-549

[6]ZeitschriftfurNaturforschung,B:ChemicalSciences,2010,vol.65,p.178-184

[7]MonatsheftefurChemie,2010,vol.141,p.479-484

[8]JournalofAgriculturalandFoodChemistry,2012,vol.60,p.1036-1041

[9]MedicinalChemistry,2012,vol.8,p.1190-1197,8

[10]ChemicalBiologyandDrugDesign,2013,vol.82,p.546-556

[11]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.192-194

[12]JournalofMolecularStructure,2016,vol.1117,p.8-16

[13]ChemicalBiologyandDrugDesign,2017,vol.89,p.47-60

[14]BioorganicandMedicinalChemistryLetters,2019,vol.29,p.449-453

[15]Molecules,2020,vol.25

[16]Bioorganicandmedicinalchemistryletters,2020

[17]MonatsheftefurChemie,2021,vol.152,p.121-135

[18]BioorganicandMedicinalChemistryLetters,2021,vol.34

[19]EuropeanJournalofMedicinalChemistry,2021,vol.217

[20]BioorganicChemistry,2021,vol.110

[21]BiomedicineandPharmacotherapy,2022,vol.146

[22]JournalofMaterialsChemistryC,2022,vol.10,p.1371-1380

75-15-0    29418-67-5    161013-20-3 

[1]JournaloftheChineseChemicalSociety,2005,vol.52,p.539-544

[2]JournalofAgriculturalandFoodChemistry,2012,vol.60,p.1036-1041

[3]ChemicalBiologyandDrugDesign,2013,vol.82,p.546-556

[4]JournalofChemicalSciences,2014,vol.126,p.827-835

[5]ChemicalBiologyandDrugDesign,2017,vol.90,p.236-243

[6]JournalofAgriculturalandFoodChemistry,2021,vol.69,p.11085-11094

[7]JournalofAgriculturalandFoodChemistry,2021,vol.69,p.15544-15553

[8]MolecularDiversity,2022

Literature fold

Title: Evaluation of small molecule tuberculostats for targeting tuberculosis infections of the central nervous system.

Journal: Central nervous system agents in medicinal chemistry20120301

Building Blocks More >
256446-67-0
256446-67-0
4-Cbz-morpholine-3-carboxylic acid
AA00BCIX | MFCD04038567
237076-69-6
237076-69-6
3,5-Bis(trifluoromethyl)-D,L-phenylalanine
AA00BCPZ | MFCD00061309
242797-29-1
242797-29-1
1-(3,4-Difluorobenzyl)-6-oxo-1,6-dihydropyridine-3-carboxylic acid
AA00BCUT | MFCD01316311
29106-51-2
29106-51-2
(2R,2'R,3S,3'R,4S)-2,2'-Bis(3,4-dihydroxyphenyl)-[4,8'-bichroman]-3,3',5,5',7,7'-hexaol
AA00BD00 | MFCD04039847
20443-38-3
20443-38-3
5-Chloro-2-(chloromethyl)-1h-benzimidazole
AA00BD5N | MFCD00060503
26993-16-8
26993-16-8
4-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)benzaldehyde
AA00BDCB | MFCD08704111
312531-87-6
312531-87-6
4-(3,5-DIMETHYL-PYRAZOL-1-YLMETHYL)-BENZOIC ACID
AA00BDIV | MFCD01821597
223433-45-2
223433-45-2
2-(Morpholinomethyl)phenylboronic acid
AA00BDQE | MFCD01319041
268209-95-6
268209-95-6
3-tert-Butoxycarbonylamino-3-naphthalen-1-yl-propionic acid
AA00BDZ8 | MFCD02090687
201608-18-6
201608-18-6
9-OXO-15S-HYDROXY-PROSTA-5Z,10,13E-TRIEN-1-OIC-3,3,4,4-D4 ACID
AA00BE6C | MFCD00135268
Submit
© 2017 AA BLOCKS, INC. All rights reserved.